Results for tag: "Dopexamine"

Dopexamine is a cardiovascular drug used to treat shock and low cardiac output syndrome. It is a synthetic catecholamine that acts as a vasopressor and inotropic agent, increasing blood pressure and cardiac output. It is used in the treatment of septic shock, cardiogenic shock, and other conditions where there is a need to increase cardiac output. It is also used to treat hypotension associated with anaesthesia and surgery. Dopexamine is available in the form of an intravenous infusion, and is usually administered in combination with other drugs. The dopexamine market is a rapidly growing segment of the cardiovascular drugs market. It is expected to benefit from the increasing prevalence of cardiovascular diseases, the growing demand for better treatments, and the increasing availability of dopexamine-based drugs. Some companies in the dopexamine market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more